Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.
I-Cheng LeeGar-Yang ChauYi-Chen YehYee ChaoTeh-Ia HuoChien-Wei SuHan-Chieh LinMing-Chih HouYi-Hsiang HuangPublished in: PloS one (2017)
In general, the risk of recurrence and survival are comparable between patients with and without secondary prevention failure. However, a higher risk of recurrence was observed in cirrhotic patients with secondary prevention failure.